Reston, VA—A pair of articles published in the May issue of The Journal of Nuclear Medicine illustrate the promise of the novel FAPI radiotracer in diagnosing, staging, and treating multiple types of ...
DULLES, Va., Dec. 29, 2025 /PRNewswire/ -- SOFIE Biosciences, an established U.S. manufacturer and developer of radiopharmaceuticals, today announced that the first patient has been dosed in one of ...
Figure 1. Clinical stage changed by FAPI PET/CT categorized by 18 F-FDG PET/CT in newly diagnosed breast cancer. Toronto, Ontario—A comparative analysis between FAPI and 18 F-FDG PET/CT for the ...
CHALFONT ST GILES, England--(BUSINESS WIRE)--GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE), a Virginia, U.S.-based company, to develop, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback